Quantitative Testing of Healthcare Provider Knowledge about YESCARTA® (axicabtagene ciloleucel) Risk Minimisation Measures

First published 25/03/2019

Last updated 22/02/2024

EU PAS number:

EUPAS28523

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

KT-EU-471-0116-appendix-16.1.1-protocol_f-redact

English (1.24 MB - PDF)View document

Updated protocol

KT-EU-471-0116-appendix-16.1.1-protocol amendment 2_f-redact

First published: 22/02/2024

English (917.82 KB - PDF)View document

Study results

Study results

KT-EU-471-0116-csr-body final_f-redact

English (1.09 MB - PDF)View document

Study report

Other information